Targeting Activated Platelets: A novel innovative approach for the sensitive detection and therapeutic targeting of various cancers and their metastases

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1124670

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Early detection and selective therapy is critical for the survival of patients with cancer. We have shown in pilot experiments that platelets accumulate at the site of tumours and thus provide the opportunity to diagnose and localise cancer and its metastases. Based on this and also newly developed biotechnological tools we aim to develop multiple innovative imaging technologies. Furthermore, we will develop novel tumour-targeted and thus tumour site-specific, side-effect poor cancer treatments.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $948,447.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Diagnosis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antibody engineering | cancer detection | cancer treatment | molecular imaging | platelets

Related Links